RHUMBLINE ADVISERS - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 143 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$180,000
-58.4%
145,089
+3.2%
0.00%
-100.0%
Q1 2017$433,000
-21.8%
140,579
+3.5%
0.00%0.0%
Q4 2016$554,000
-34.3%
135,885
+2.4%
0.00%
-50.0%
Q3 2016$843,000
+16.9%
132,760
-0.7%
0.00%0.0%
Q2 2016$721,000
-25.3%
133,760
+16.1%
0.00%
-33.3%
Q1 2016$965,000
+9.2%
115,250
+3.0%
0.00%0.0%
Q4 2015$884,000
+1.5%
111,910
+9.4%
0.00%0.0%
Q3 2015$871,000
-30.8%
102,320
+0.5%
0.00%
-25.0%
Q2 2015$1,259,000
+9.1%
101,831
+4.8%
0.00%
+33.3%
Q1 2015$1,154,000
+25.4%
97,141
+19.4%
0.00%0.0%
Q4 2014$920,000
+28.9%
81,381
+0.1%
0.00%
+50.0%
Q3 2014$714,000
+21.8%
81,271
+1.1%
0.00%0.0%
Q2 2014$586,000
+53.4%
80,381
+6.1%
0.00%
+100.0%
Q1 2014$382,000
-10.7%
75,771
-5.5%
0.00%0.0%
Q4 2013$428,000
+35.0%
80,191
-4.0%
0.00%0.0%
Q3 2013$317,000
-41.5%
83,491
+3.7%
0.00%
-50.0%
Q2 2013$542,00080,4820.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders